Researchers develop therapy that can detect lung cancer at early stage

New Delhi: Lung cancer, the most common cause of cancer-related deaths worldwide, is tough to detect at early stages, making it difficult to treat. However, the scientists may soon have a solution for it. The researchers from Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) have developed a diagnostic therapy for lung cancer that can detect the disease at an early stage paving the way for personalized medicine,"said the Ministry of Science and Technology on Sunday. ....read more

Acute kidney injury can develop in otherwise healthy COVID-19 patients.

Join us today at 7:00 PM on MEDtalks with Dr K K Aggarwal as he discusses the detection of early kidney injury with Dr. Georgi Abraham. Just click on www.facebook.com/drkkaggarwal or https://perfecthealthmela.com/vevent/general-webinar.php

CMAAO Coronavirus Facts and Myth Buster: Obesity and Virology

With input from Dr Monica Vasudev 1076: Patients with COVID-19 and obesity [BMI > 30 kg/m2] have a higher viral load and the virus may persist for longer In a large multicentre trial, those with a BMI < 25 kg/m2 and COVID-19 took around 14 days to recover completely, those with BMI 25-30 kg/m2 took around 17 days, and those with a BMI > 30 kg/m2 took nearly 19-20 days. Dror Dicker, MD, from Hasharon Hospital, Petah Tikva, Israel, presented the preliminary results of the work at the opening plenary of the virtual European and International Congress on Obesity (ECOICO) 2020. ....read more

CMAAO Coronavirus Facts and Myth Buster: Low dose steroids

With input from Dr Monica Vasudev1075: Meta-analysis finds corticosteroids reduce risk of death in critically ill COVID-19 patients DG Alerts excerpts: A meta-analysis published in the Journal of the American Medical Association suggested that the use of systemic corticosteroids in critically ill patients with COVID-19 was tied to lower 28-day all-cause mortality compared to usual care or placebo. The benefit was the same irrespective of age, sex or the duration of illness. Among the participants, 678 patients had been randomized to receive systemic dexamethasone, hydrocortisone or methylprednisolone; remaining 1025 patients received usual care or placebo. The median age was 60 years, and 29% were women. The primary outcome was all-cause mortality up to 30 days following randomization and was determined before any outcome data were available from any of the studies. ....read more

Mindfulness meditation

Sit on a straight-backed chair or you may also sit cross-legged on the floor. Move your focus to a particular aspect of your breathing, for instance, the sensation of air flowing into the nostrils and out of the mouth, or the movement of your abdomen rising and falling as you inhale and exhale. After narrowing your concentration this way, start to expand your focus. Move your awareness towards sounds, sensations, and ideas. ....read more

Video of The day

Understanding all about fever

Healthcare News Monitor

Bharat Biotech gets DCGI nod for PHASE II trials of COVAXIN

Express Pharma

According to a report by The Indian Express, the Drugs Controller General of India (DCGI) has given clearance to Bharat Biotech for conducting Phase II human clinical trials of its indigenously developed Covaxin. The report informed that the subject expert committee (SEC) has recommended that the trial will be conducted on 380 participants. A letter from Joint Drugs Controller Dr S Eswara Reddy, dated September 3, has notified the company about this. Reportedly, the first phase of the Covaxin trial was done with 375 participants from across 12 sites.

Alembic Pharma arm gets tentative USFDA nod for drug to treat pulmonary arterial hypertension

Outloook-THE NEWS SCROLL

New Delhi, Sep 7 (PTI) Drug firm Alembic Pharmaceuticals on Monday said its subsidiary has received tentative approval from the US health regulator for Treprostinil injection indicated for the treatment of pulmonary arterial hypertension. The tentatively approved product is therapeutically equivalent to the reference listed drug product Remodulin injection of United Therapeutics Corp. Alembic Global Holdings SA has received tentative approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Treprostinil Injection in the strengths of 20 mg/20 ml (1 mg/ml), 50 mg/20 ml (2.5 mg/ml), 100 mg/20 ml (5 mg/ml), and 200 mg/20 ml (10 mg/ml), multiple-dose vials, Alembic Pharmaceuticals said in a regulatory filing.

COVID-19 reinfection: Bengaluru woman tests positive for coronavirus again in a month

LiveMint

A woman was infected with the coronavirus after recovering from an initial bout in July in what doctors claimed to be the first case showing that re-infection may occur within a few months. The 27-year-old woman from Bengaluru has tested positive again nearly a month after she was treated and discharged from hospital, Fortis Hospital confirmed on Sunday. This is the first confirmed case of COVID-19 reinfection in Bengaluru, the Fortis Hospital said. Dr Pratik Patil, consultant, infectious diseases, Fortis Hospital, Bannerghatta Road, said, "In the first week of July, the patient was symptomatic (fever, cough and sore throat) and was tested positive. She was admitted to the hospital and recovered well."

India: How a Muslim doctor was incarcerated for raising his voice

Aljazeera

An Indian doctor who was jailed for more than seven months for criticising a controversial citizenship law was released on Tuesday night after a court in northern Uttar Pradesh state called his incarceration "illegal". Dr Kafeel Khan told Al Jazeera he was physically tortured while in captivity, which included him being stripped of his clothes and beaten and deprived of food for days. "It was very hard for the whole family. My 65-year-old mother was forced to visit the courts during the peak of the coronavirus pandemic," he said.